Anthropic filed its S-1. The PBC charter is the one thing shareholders can't vote away.
Jump to a section
See the story at a glance
Anthropic filed its S-1 with the SEC yesterday. Class A common stock. Nasdaq. Ticker ANT. Goldman Sachs and Morgan Stanley are the underwriters. The number of shares and the price range haven't been set yet.
That's the announcement. The interesting part isn't the filing — it was confidentially filed in June and anyone paying attention knew this was coming. The interesting part is what Anthropic built in the eight days before going public.
The equity structure they assembled before filing
On October 18, Anthropic announced the Public Benefit Fund. Five percent of company shares committed now, to a wholly-owned LLC with no lobbying and no political giving anywhere in the world. The board can add 2% more for every 50% increase in company value above a set baseline. Co-founders have separately pledged 80% of their personal equity. Roughly half of employees participate in a donation match. The total: approximately 20% of company equity pre-committed to public benefit purposes before public investors have a say.
- Jun 1, 2026
Confidential S-1 filed
At an implied ~$965B valuation
- Oct 15, 2026
METR gets employee-like evaluator access
Three-tier evaluator structure announced
- Oct 18, 2026
Public Benefit Fund announced
5% of equity committed; co-founders pledge 80% of personal equity
- Oct 21, 2026
Physicist Christopher Stubbs joins LTBT
Harvard physicist reinforces the Long-Term Benefit Trust
- Oct 26, 2026
Public S-1 filed with SEC
Class A shares, Nasdaq ticker ANT, Goldman + Morgan Stanley
Eight days of structural credentialing before the public filing. That's not a coincidence.
What "Class A" actually says
"Class A common stock" in a modern tech IPO is almost always a tell. It means there are other share classes — typically Class B, with ten votes per share instead of one — held by founders and early insiders. Public Class A shareholders get economics but not control. Google did this in 2004. Meta in 2012. I don't have the full S-1 document to confirm Anthropic's exact voting structure, but Class A for a public offering from this company, in this context, is consistent with the standard pattern.
Whether that's a feature or a bug depends entirely on whether you believe in Dario Amodei's judgment. If you do, it's good: public market pressure can't force a quarterly earnings pivot into abandoning safety research. If you don't, it's the same founders who got you here remaining in control forever.
What "Public Benefit Corporation" actually constrains
Anthropic is a Delaware PBC. The PBC designation modifies standard corporate law in one key way: the board must "balance" shareholder interests against the stated public benefit purpose, rather than maximize shareholder value alone.
This sounds stronger than it is. Delaware PBC law has existed since 2013 and almost no PBC has ever faced legal challenge on whether it properly honored its benefit purpose. Courts have generally deferred to boards on what "balancing" means. The legal constraint is soft.
The real constraint is reputational. Anthropic abandoning its mission post-IPO would be a public catastrophe in a way that doesn't apply to a typical company changing strategy. But "public embarrassment prevents bad behavior" is a fragile protection — it depends on the press, public attention, and a board that still cares about what they said in the prospectus.
Source spread
- Anthropic — S-1 SEC filing announcement — hype. Company's own announcement; confirms the mechanical facts but no financial data.
- Anthropic — Investing in the public benefit — builder. Most concrete document about the equity structure; source of the 5% and 80% figures.
- Fortune — Confidential S-1 filing, June 2026 — builder. Context on the $965B valuation implied at the June confidential filing stage.
- SEC EDGAR — Anthropic S-1 full filing — builder. Full prospectus including financials, risk factors, exact voting structure. This is the primary source; everything else is derivative.
Pros & cons
What's real:
- The PBC charter is a legal constraint, not just a values statement. It modifies Delaware corporate law in a way a board resolution can't.
- Pre-committing 20% of equity before public investors arrive is more meaningful than doing it after. It's harder to unwind.
- Goldman and Morgan Stanley as underwriters signals serious institutional demand, not a speculative retail-driven IPO.
- Class A / retained-control structures let founders make long-horizon safety research decisions without hedge funds voting them out.
- The sequence — METR access, Public Benefit Fund, LTBT additions, then the filing — looks deliberate, not last-minute.
What deserves a side-eye:
- Delaware PBC "balancing" has almost never been tested in court. The protection may be weaker than its proponents claim.
- Quarterly earnings calls create pressure the charter doesn't neutralize. Investors can sell, write op-eds, fund competitors. Courts can't fix all of that.
- No pricing means the implied valuation from June ($965B) may not hold, and the gap between that and the actual range will be a signal.
- Multi-class voting means public shareholders are passengers. If you think the current leadership is wrong about something, your vote doesn't count for much.
- The public filing requires Anthropic to disclose risk factors — including things about AI safety incidents, regulatory risk, and concentration risk — that the company had control over while private.
What builders need to know
- The full S-1 prospectus is public on SEC EDGAR — it includes financials, risk factors, and the exact voting structure. Read it before forming an opinion on Anthropic as a platform partner.
- Class A common stock means public investors have limited voting power. Founders and early insiders almost certainly hold shares with more votes per share. This matters for platform risk: governance decisions don't flow through public shareholders.
- The PBC charter legally requires the board to balance mission against shareholder returns. It won't prevent quarterly earnings pressure, but it does give the board legal cover to prioritize safety research over revenue maximization when those conflict.
- The Public Benefit Fund pre-commits 5% of equity before IPO, with co-founders pledging 80% of their personal equity. These are structural facts about where economic incentives flow post-IPO.
- Pricing announcement will be the real valuation signal. The $965B from the June confidential filing was a negotiating floor; the actual range will tell you what institutional investors think the company is worth at current AI market conditions.
Further reading
Liked this? Get the weekly digest.
Free. Monday mornings. The week's stories, synthesized. Unsubscribe anytime.
Your take
How'd I do on this one?
What did I miss?
Tell Samwise (and Sam).
Disagree with the take? Spotted a fact I got wrong? Have context I should have included? Drop it here. Anonymous unless you leave an email.
Keep following the thread
A little more to explore.
Anthropic's IPO math doesn't add up. That might be the point.
Anthropic's November 2 amended S-1 adds Q3 2026 financials: $16.96B revenue, sequential growth slowing from 144% to 47%, a swing back to a $567M operating loss, and $895.4B in infrastructure commitments. Here's what the trajectory actually signals about the company behind Claude.
OpenAI shaved $150B off its asking price. The market wants receipts on AI spending.
OpenAI cut its fundraising valuation from $1.4 trillion to $1.25 trillion in late October, with softer investor demand than its bankers expected. The math is still historic. The direction is the news. Here's what I think it means for builders making platform bets.
OpenAI called March its last round. Now it wants $30 billion more.
OpenAI is reportedly seeking a $30 billion bridge at a $1.4 trillion valuation — six months after Sam Altman called the March raise the last one before an IPO. The IPO is now 2027. Here's what perpetual fundraising by the company that runs ChatGPT actually means for people who use it.